How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?

by Philippe Colucci, Jacques Turgeon, Murray P. Ducharme
Published 2011-06-01

Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir,...

by Adrienne Carmel Muller, Murray P Ducharme, Isadore Kanfer
Published 2018-08-01

Rethinking bioequivalence and equivalence requirements of orally inhaled drug products

by Dina Al-Numani, Philippe Colucci, Murray P. Ducharme
Published 2015-12-01

Novel Population Pharmacokinetic Method Compared to the Standard Noncompartmental Approach to Assess Bioequivalence of Iron Gluconate Formulations

by Corinne Seng Yue, Keith Gallicano, Line Labbé, Murray P Ducharme
Published 2013-07-01

Influence of Different Populations on Pharmacokinetic Bioequivalence Results: Can We Extrapolate Bioequivalence Results from One Population to Another?

by Deniz Ozdin, Murray P. Ducharme, France Varin, Anders Fuglsang, Dina Al-Numani
Published 2020-10-01

Revisiting FDA’s 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations

by Deniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, Philippe Colucci, Isadore Kanfer, Murray P. Ducharme
Published 2018-11-01